Vertical Augmentation With Osteon at Dental Implant Placement
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Dental implants are a valid and reliable method to replace missing teeth. The major requirement for their success is an adequate volume of bone into which they can be placed. One widely used method to augment bone at the time of placing the implant is to use a bone substitute rather than taking a block bone graft from the patient. Successful augmentation in the vertical direction has often proved difficult, however, the investigators have developed a technique to achieve this in the investigators patients using a synthetic bone substitute, Osteon (Implantium, CE0120) in an attempt to avoid patients having to undergo another unnecessary surgical procedure.
| Condition | Intervention |
|---|---|
|
Tooth Injuries Tooth Abnormalities |
Device: Osteon bone graft |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | An Evaluation of Vertical Augmentation of Alveolar Bone With Osteon at Dental Implant Placement |
- The success of dental implants in alveolar bone augmented in the vertical direction with Osteon [ Time Frame: 3 years ] [ Designated as safety issue: No ]The implants will be deemed successful at each time point if the radiographic bone level remains at 2 mm above the level of the implant, i.e. at the same height as when placed. Given that we know precisely the dimensions of the abutments placed in the implant, this provides the necessary calibration in order to undertake this assessment. If the bone level is lost, the procedure will be deemed to have failed.
| Estimated Enrollment: | 100 |
| Study Start Date: | September 2010 |
| Estimated Study Completion Date: | September 2015 |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Osteon
Patients requiring dental implants with deficient alveolar bone height
|
Device: Osteon bone graft
Osteon bone substitute placed to a height of 2 mm above the top of the dental implant
Other Names:
|
Detailed Description:
Primary Objective
• To determine the success of dental implants in alveolar bone augmented in the vertical direction with Osteon.
Secondary Objectives • To determine the long term success of dental implants in this augmented bone.
Primary Endpoint
• Radiographically assessed vertical height of alveolar ridge formation following Osteon augmentation.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Private specialist dental implant clinic
Inclusion Criteria:
- missing one or two teeth
- bounded saddle
- healthy (ASA grade I & II) adult
Exclusion Criteria:
- smoker
- significant medical problem (ASA III or above)
Contacts and Locations| Contact: Richard J Oliver, BDS PhD | 00448453096323 | richard.oliver@redonline.org |
| Contact: Jason Buglass, BDS | 00441743 452369 | jason@implantium.co.uk |
| United Kingdom | |
| Oracle Dental Clinics | Not yet recruiting |
| Shrewsbury, Shropshire, United Kingdom, SY1 3GW | |
| Principal Investigator: | Richard J Oliver, BDS PhD | Research and Education in Dentistry |
More Information
No publications provided
| Responsible Party: | Dr Richard Oliver, Research and Education in Dentistry |
| ClinicalTrials.gov Identifier: | NCT01162629 History of Changes |
| Other Study ID Numbers: | RED001 |
| Study First Received: | July 5, 2010 |
| Last Updated: | July 14, 2010 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by Research and Education in Dentistry:
|
bounded saddles missing teeth dental implants Tooth, Nonvital |
Additional relevant MeSH terms:
|
Congenital Abnormalities Tooth Abnormalities Tooth Injuries Stomatognathic System Abnormalities |
Stomatognathic Diseases Tooth Diseases Wounds and Injuries |
ClinicalTrials.gov processed this record on May 22, 2013